These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 19858761)

  • 1. Medication and parent training in children with pervasive developmental disorders and serious behavior problems: results from a randomized clinical trial.
    Aman MG; McDougle CJ; Scahill L; Handen B; Arnold LE; Johnson C; Stigler KA; Bearss K; Butter E; Swiezy NB; Sukhodolsky DD; Ramadan Y; Pozdol SL; Nikolov R; Lecavalier L; Kohn AE; Koenig K; Hollway JA; Korzekwa P; Gavaletz A; Mulick JA; Hall KL; Dziura J; Ritz L; Trollinger S; Yu S; Vitiello B; Wagner A;
    J Am Acad Child Adolesc Psychiatry; 2009 Dec; 48(12):1143-54. PubMed ID: 19858761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of risperidone and parent training on adaptive functioning in children with pervasive developmental disorders and serious behavioral problems.
    Scahill L; McDougle CJ; Aman MG; Johnson C; Handen B; Bearss K; Dziura J; Butter E; Swiezy NG; Arnold LE; Stigler KA; Sukhodolsky DD; Lecavalier L; Pozdol SL; Nikolov R; Hollway JA; Korzekwa P; Gavaletz A; Kohn AE; Koenig K; Grinnon S; Mulick JA; Yu S; Vitiello B;
    J Am Acad Child Adolesc Psychiatry; 2012 Feb; 51(2):136-46. PubMed ID: 22265360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Research Units of Pediatric Psychopharmacology (RUPP) autism network randomized clinical trial of parent training and medication: one-year follow-up.
    Arnold LE; Aman MG; Li X; Butter E; Humphries K; Scahill L; Lecavalier L; McDougle CJ; Swiezy NB; Handen B; Wilson K; Stigler KA
    J Am Acad Child Adolesc Psychiatry; 2012 Nov; 51(11):1173-84. PubMed ID: 23101743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors and moderators of parent training efficacy in a sample of children with autism spectrum disorders and serious behavioral problems.
    Farmer C; Lecavalier L; Yu S; Eugene Arnold L; McDougle CJ; Scahill L; Handen B; Johnson CR; Stigler KA; Bearss K; Swiezy NB; Aman MG
    J Autism Dev Disord; 2012 Jun; 42(6):1037-44. PubMed ID: 21822762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trial design challenges when combining medication and parent training in children with pervasive developmental disorders.
    Scahill L; Aman MG; McDougle CJ; Arnold LE; McCracken JT; Handen B; Johnson C; Dziura J; Butter E; Sukhodolsky D; Swiezy N; Mulick J; Stigler K; Bearss K; Ritz L; Wagner A; Vitiello B
    J Autism Dev Disord; 2009 May; 39(5):720-9. PubMed ID: 19096921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders.
    Shea S; Turgay A; Carroll A; Schulz M; Orlik H; Smith I; Dunbar F
    Pediatrics; 2004 Nov; 114(5):e634-41. PubMed ID: 15492353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of parent training vs parent education on behavioral problems in children with autism spectrum disorder: a randomized clinical trial.
    Bearss K; Johnson C; Smith T; Lecavalier L; Swiezy N; Aman M; McAdam DB; Butter E; Stillitano C; Minshawi N; Sukhodolsky DG; Mruzek DW; Turner K; Neal T; Hallett V; Mulick JA; Green B; Handen B; Deng Y; Dziura J; Scahill L
    JAMA; 2015 Apr; 313(15):1524-33. PubMed ID: 25898050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 3-year naturalistic study of 53 preschool children with pervasive developmental disorders treated with risperidone.
    Masi G; Cosenza A; Mucci M; Brovedani P
    J Clin Psychiatry; 2003 Sep; 64(9):1039-47. PubMed ID: 14628979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Riluzole as an adjunctive therapy to risperidone for the treatment of irritability in children with autistic disorder: a double-blind, placebo-controlled, randomized trial.
    Ghaleiha A; Mohammadi E; Mohammadi MR; Farokhnia M; Modabbernia A; Yekehtaz H; Ashrafi M; Hassanzadeh E; Akhondzadeh S
    Paediatr Drugs; 2013 Dec; 15(6):505-14. PubMed ID: 23821414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risperidone in children with autism and serious behavioral problems.
    McCracken JT; McGough J; Shah B; Cronin P; Hong D; Aman MG; Arnold LE; Lindsay R; Nash P; Hollway J; McDougle CJ; Posey D; Swiezy N; Kohn A; Scahill L; Martin A; Koenig K; Volkmar F; Carroll D; Lancor A; Tierney E; Ghuman J; Gonzalez NM; Grados M; Vitiello B; Ritz L; Davies M; Robinson J; McMahon D;
    N Engl J Med; 2002 Aug; 347(5):314-21. PubMed ID: 12151468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial.
    Asadabadi M; Mohammadi MR; Ghanizadeh A; Modabbernia A; Ashrafi M; Hassanzadeh E; Forghani S; Akhondzadeh S
    Psychopharmacology (Berl); 2013 Jan; 225(1):51-9. PubMed ID: 22782459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risperidone treatment of autistic disorder: longer-term benefits and blinded discontinuation after 6 months.
    Research Units on Pediatric Psychopharmacology Autism Network
    Am J Psychiatry; 2005 Jul; 162(7):1361-9. PubMed ID: 15994720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term safety and efficacy of risperidone for the treatment of disruptive behavior disorders in children with subaverage IQs.
    Turgay A; Binder C; Snyder R; Fisman S
    Pediatrics; 2002 Sep; 110(3):e34. PubMed ID: 12205284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropsychological effects of risperidone in children with pervasive developmental disorders: a blinded discontinuation study.
    Troost PW; Althaus M; Lahuis BE; Buitelaar JK; Minderaa RB; Hoekstra PJ
    J Child Adolesc Psychopharmacol; 2006 Oct; 16(5):561-73. PubMed ID: 17069545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risperidone monotherapy in preschool children with pervasive developmental disorders.
    Masi G; Cosenza A; Mucci M; De Vito G
    J Child Neurol; 2001 Jun; 16(6):395-400. PubMed ID: 11417603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical antipsychotics for disruptive behaviour disorders in children and youths.
    Loy JH; Merry SN; Hetrick SE; Stasiak K
    Cochrane Database Syst Rev; 2012 Sep; (9):CD008559. PubMed ID: 22972123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risperidone Combination Therapy With Propentofylline for Treatment of Irritability in Autism Spectrum Disorders: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
    Behmanesh H; Moghaddam HS; Mohammadi MR; Akhondzadeh S
    Clin Neuropharmacol; 2019; 42(6):189-196. PubMed ID: 31725473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risperidone versus haloperidol in children and adolescents with AD : a randomized, controlled, double-blind trial.
    Miral S; Gencer O; Inal-Emiroglu FN; Baykara B; Baykara A; Dirik E
    Eur Child Adolesc Psychiatry; 2008 Feb; 17(1):1-8. PubMed ID: 18080171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risperidone in preschool children with autistic spectrum disorders: an investigation of safety and efficacy.
    Luby J; Mrakotsky C; Stalets MM; Belden A; Heffelfinger A; Williams M; Spitznagel E
    J Child Adolesc Psychopharmacol; 2006 Oct; 16(5):575-87. PubMed ID: 17069546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risperidone in the treatment of behavioral disturbances in children and adolescents with borderline intellectual functioning: a double-blind, placebo-controlled pilot trial.
    Van Bellinghen M; De Troch C
    J Child Adolesc Psychopharmacol; 2001; 11(1):5-13. PubMed ID: 11322745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.